Teva Pharmaceutical Industries
(NYSE) TEVA
Teva Pharmaceutical Industries Financials at a Glance
Market Cap
$38.68B
Revenue (TTM)
$17.35B
Net Income (TTM)
$1.56B
EPS (TTM)
$1.35
P/E Ratio
24.68
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$33.25
Volume
75
Open
$33.47
Price
$33.25
Volume
75
Open
$33.47
Previous Close
$33.21
Daily Range
$32.96 - $34.14
52-Week Range
$14.99 - $37.35
Estimated Earnings Date
Jul 29, 2026
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$33.25
Volume
75
Open
$33.47
Previous Close
$33.21
Daily Range
$32.96 - $34.14
52-Week Range
$14.99 - $37.35
Estimated Earnings Date
Jul 29, 2026
TEVA News
TEVA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Teva Pharmaceutical Industries
Industry
Pharmaceuticals
Sector
Health CareEmployees
33,346
CEO
Richard Francis
Website
www.tevapharm.comHeadquarters
Tel Aviv, 6944020, IL
TEVA Financials
Key Financial Metrics (TTM)
Gross Margin
52.06%
Operating Margin
18.83%
Net Income Margin
9.03%
Return on Equity
20.79%
Return on Capital
8.53%
Return on Assets
3.90%
Earnings Yield
4.05%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$38.68B
Shares Outstanding
1.16B
Volume
75
Avg. Volume
6.20M
Financials (TTM)
Gross Profit
$9.03B
Operating Income
$2.29B
EBITDA
$3.27B
Operating Cash Flow
$1.71B
Capital Expenditure
-$542.00M
Free Cash Flow
$1.17B
Cash & ST Invst.
$3.74B
Total Debt
$16.91B
Teva Pharmaceutical Industries Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.98B
+2.3%
Gross Profit
$1.97B
+5.1%
Gross Margin
49.54%
N/A
Market Cap
$38.68B
N/A
Market Cap/Employee
$1.05M
N/A
Employees
37,000
N/A
Net Income
$369.00M
+72.4%
EBITDA
$877.00M
-8.0%
Quarterly Fundamentals
Total Cash
$3.74B
+120.5%
Total Debt
$16.91B
-0.2%
Accounts Receivable
$3.39B
+0.3%
Inventory
$3.18B
-2.2%
Long Term Debt
$14.30B
-13.5%
Short Term Debt
$2.61B
+520.4%
Return on Assets
3.90%
N/A
Return on Invested Capital
12.27%
N/A
Free Cash Flow
-$208.00M
+10.3%
Operating Cash Flow
-$40.00M
+61.9%